Regulatory & market intelligence for alternative tobacco & nicotine products
The TobaccoIntelligence nicotine hub highlights our in-depth coverage of nicotine science and regulatory issues. Topics covered include science, health, addiction, cessation and policy. Commercial and legal perspectives are both featured.
Swedish Match posted an operating profit of nearly SEK 7bn ($845m) in 2020, up 23% on the previous year, thanks largely to a good performance by its ZYN nicotine pouches and record US sales The company posted an operating profit of nearly SEK 7bn ($845m) in 2020, an increase of 23% against 2019.
All the stories from the TobaccoIntelligence regulatory Live Alerts in one user-friendly database, updated every month.
This regulatory tool consolidates all of our global regulatory Live Alerts, collected in Excel database format, allowing you to filter information by date, region, country and legislative area.
Apart from the obvious, what has 2020 brought us? And in particular, what has it brought to the world of alternative tobacco and tobacco alternatives?
This report analyses the current and likely near-future regulatory framework for nicotine pouches in Illinois, Ohio, Georgia, North Carolina, and Michigan – the sixth to tenth largest in the US by population
This report looks at the regulatory framework for nicotine pouches in the five largest US states by population. A similar report will follow, covering the next five largest states
The Ministry of Health has proposed that the enforcement of the provisions affecting labelling and health warnings rules should be postponed by six months
Tobacco pouches (snus) are banned throughout the EU except in Sweden. However, there is no EU-level regulation of pouches that contain nicotine but not tobacco – and they are the subject of this report
Nicotine and CBD are perceived as the bad guy and the good guy of health and wellness – but could putting the two together make commercial sense if it can help smokers break the habit?
Synthetic nicotine, created from chemicals in a lab, not derived from tobacco, is not a specifically regulated product in the US so its legal status is subject to interpretation, as outlined in detail in this report
Canada’s top health authority has issued a warning against nicotine pouches, saying they may pose “various serious health risks” to users, and ordered the recall of an unauthorised product being sold in Toronto
Taxes collected on “e-liquids and other nicotine products” in Sweden in 2019 amounted to SEK79.5m (€7.55m) – a figure believed to come mainly from products newly introduced into the market
Health Canada appears to have changed its mind about nicotine pouches, declaring that they should be regulated as drugs even if no “explicit” claim is made for any health benefit
Reynolds American has submitted a premarket tobacco product application (PMTA) to the US Food and Drug Administration (FDA) for its Velo nicotine lozenges to remain on the market after September
The Australian Therapeutic Goods Administration (TGA) has issued a final decision not to amend the country’s Poisons Standard – a decision which leaves the sale of heated tobacco products banned in the country
Lawmakers in the Latvian parliament (Saeima) want a ban on tobacco-alternative products and have submitted a draft law that would crack down on nicotine pouches and heated tobacco devices
The Belarus government has made a first firm step towards restricting the sale of tobacco-free nicotine-containing products, including tobacco-free snus (sometimes known as “white pouch”), to minors and in some retailing spaces
Voters in the US state of Colorado will decide in November whether to support a bill to increase taxes on tobacco after lawmakers put forward a plan for rises to be phased in over the next seven years
Hong Kong will reintroduce a bill to ban tobacco-alternative products after local elections in September. The Legislative Council ended discussions on the existing bill due to lack of time before its term ends in July
This reports takes on a Q&A structure, providing a comprehensive overview of US regulations of oral nicotine products
Smokers in the US state of California can get free nicotine patches by mail to help them quit, as part of a research project on public health during the COVID-19 crisis
Altria has submitted premarket tobacco product applications (PMTAs) to the US Food and Drug Administration (FDA) for 35 varieties of its On! nicotine pouches
In Europe, chemical substances are classified according to their toxicity levels. Those that are deemed potentially harmful are subject to rules on packaging and labelling, as explained in this report
All TobaccoIntelligence’s COVID-19-related news briefings can now be found in one place here
The French government is temporarily restricting sales of nicotine replacement therapy (NRT) products following research suggesting nicotine patches could be used in treatment for COVID-19
In recent years, there has been interest in adding nicotine to all sorts of products to provide smokers a healthier way to satisfy their craving. This report assesses the possibility of adding nicotine to food in the EU
Organisers of two major conferences and exhibitions on nicotine delivery are hoping the events can still go ahead despite the global coronavirus outbreak and a number of other event cancellations and postponements
This report covers the regulatory landscape for tobacco-free and tobacco-containing snus products in Russia. Retail sale of snus containing tobacco has been prohibited in Russia since 2015, but the law does not apply to tobacco-free nicotine snus
The regulation of tobacco-free pouches is controversial, due to its novelty but also because it is not clear under which regulatory regime these products fall. This report covers Sweden’s regulation of tobacco-free snus
Further evidence that reducing the amount of nicotine in combustibles does not lead to heavier smoking may provide encouragement for those who want to see reductions legally mandated
This regulatory tracker provides a summary of the regulation of tobacco-free pouches globally as specified by the authorities in each country in answer to TobaccoIntelligence’s inquiries or after specific information has otherwise emerged. Its purpose is to provide an objective overview of regulation across the selected countries rather than our analysis or hypothesis regarding the most likely scenario.
Is nicotine really as addictive as heroin, as the US surgeon general claims? And what does that really mean, anyway? ECigIntelligence pits the scientific evidence against the easy soundbite
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the TobaccoIntelligence team.
